Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Arch Neurol. 2009 Nov;66(11):1400–1406. doi: 10.1001/archneurol.2009.210

Table 3.

HRs and 95% CIs for Lipid Parameters and Risk of Ischemic Stroke Using Dichotomous Definitions

Lipid Parameter Unadjusted HR (95% CI) Adjusted HR (95% CI)a
HDL-C level (men, <40 mg/dL; women, <50 mg/dL) 1.14 (0.84–1.55) 1.21 (0.87–1.69)
LDL-C level > 130 mg/dL 0.68 (0.49–0.93) 0.71 (0.51–0.98)
 Taking cholesterol-lowering medicationb 0.40 (0.23–0.72)
 Not taking cholesterol-lowering medicationb 1.09 (0.73–1.62)
TG level > 200 mg/dL 1.4 (0.94–2.08) 1.19 (0.77–1.84)
TG:HDL-C ratio > 2 1.03 (0.75–1.43) 0.88 (0.62–1.26)
Non–HDL-C level > 160 mg/dL 0.75 (0.55–1.03) 0.74 (0.53–1.02)
 Taking cholesterol-lowering medicationb 0.48 (0.27–0.84)
 Not taking cholesterol-lowering medicationb 1.15 (0.77–1.73)
Total cholesterol level > 240 mg/dL 0.82 (0.54–1.25) 0.76 (0.48–1.18)
 Taking cholesterol-lowering medicationb 0.52 (0.25–1.08)
 Not taking cholesterol-lowering medicationb 1.38 (0.78–2.45)
Total cholesterol:HDL-C ratio in the upper quartile 0.97 (0.69–1.39) 0.79 (0.54–1.16)

Abbreviations: CI, confidence interval; HDL-C, high-density lipoprotein cholesterol; HR, hazard ratio; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides.

SI conversion factors: See Table 2.

a

Adjusted for age, sex, race/ethnicity, education, hypertension, diabetes mellitus, other lipid profile parameters, smoking, coronary artery disease, moderate alcohol consumption, and physical activity.

b

Stratified models based on an interaction term with lipid-lowering medications, P <.05.